Cancer - 2 Miracle combinations exist.

[Guest guest]

Medline is www.ncbi.nlm.nih.gov/pubmed ; type in the number or words to see the

article.

Two combinations have been invented to combat cancer, and both inspire

miraculous hope.

Both combinations use TAC (Thiazolidined-4-carboxylic acid) and a form of DOX.

In 1979, Dr. Gosalvez and Dr. Brugarolas were the first to discover that TAC

caused

the " ...disappearance of evidence of cancer. " in a clinical trial; Medline

6101417.

Dr. Gosalvez was Director of Spanish Biochemical Research from 1970 to

2000.

According to Dr. Weiss, ever since it was developed in the 1960s, DOX has been

the most effective anti-cancer medicine; Medline 1462166.

DOX is known also as Doxorubicin and Adriamycin; because of its color and

toxicity,

DOX is also commonly referred to as 'The Red Devil'.

In 1989, Dr. Gosalvez developed a less toxic form of DOX and called it

'Quelamycin'.

COMBINATION NO.1 - TAC & Quelamycin were administered to " terminal cancer

patients " in

U.S. Military Hospitals from 1990 to 2000, and the procedure was a success

according to Dr. Gosalvez.

The procedure was implemented because of the influence of King of Spain

and President Bush (41).

(Information obtained in letters to S. from Dr. Gosalvez; beginning

in July 20, 2001.)

In 1996, Dr. V. Schally, a 1977 Nobel Prize winner in Medicine, invented

2-pyrrolinodoxorubicin

which is " 500-1000 times more potent " than DOX; Medline 8637897 and 8692981.

COMBINATION NO. 2 - A January, 1997 report describes the miraculous laboratory

results

obtained by Dr. Schally when he combined TAC & 2-pyrrolinodoxorubicin and

designated

the compound 'AN-257'; Medline 9012839. Particular attention should be given to

Table 3. which describes

how many " ...times higher than DOX... " AN-257 was in causing the " Inhibition of

growth " upon

these human cancer cell lines; divide DOX numbers by AN-257 numbers -

Pancreatic - 335

SCLC (Small Cell Lung Cancer) -

1657

Prostate - 224

Gastric (Stomach) - 857.

Unfortunately, neither Dr. Schally, nor has anyone, ever called for a clinical

trial to determine the effect

that the TAC & 2-pyrrolinodoxorubicin combination might have upon human beings.

Proof - type THIAZOLIDINE-4-CARBOXYLIC ACID 2-PYRROLINODOXORUBICIN into Medline,

and you will

see that Dr. Schally's January, 1997 report is the only entry.

S. , The Cure for Cancer? , http://cures for cancer.ws/tac-cure.htm